Walleye Capital’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.08M Sell
15,005
-52,895
-78% -$4.1M ﹤0.01% 3394
2026
Q2
$4.66M Buy
+67,900
New +$3.86M 0.02% 867
2026
Q1
– Sell
-14,787
Closed -$1.92M – 5049
2025
Q4
$1.92M Buy
14,787
+6,951
+89% +$954K 0.01% 1903
2025
Q3
$844K Buy
+7,836
New +$854K ﹤0.01% 2223
2022
Q3
– Sell
-314
Closed -$13K – 3585
2022
Q2
$13K Buy
+314
New +$21.3K ﹤0.01% 1973
2021
Q1
– Sell
-664
Closed -$242K – 1366
2020
Q4
$242K Buy
+664
New +$231K 0.02% 677

Other funds holding WGS

Walleye Capital's WGS Position: Q3 2026 in Review

Walleye Capital reduced its GeneDx Holdings (WGS) stake by 78% in Q3 2026, selling an estimated $4.1M and leaving 15,005 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #3394.

Walleye Capital first reported a position in WGS in Q4 2020 and has held it in 6 quarters since. The position peaked at $4.66M in Q2 2026. 218 funds tracked by Wall St. Rank hold WGS as of Q3 2026.

  • Walleye Capital held 15,005 shares of GeneDx Holdings worth $1.08M as of Q3 2026.
  • Walleye Capital sold 52,895 GeneDx Holdings shares in Q3 2026, an estimated $4.1M.
  • GeneDx Holdings made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #3394 holding.
  • Walleye Capital first reported a position in GeneDx Holdings in Q4 2020 and has held it in 6 quarters since.
  • Walleye Capital's GeneDx Holdings position peaked at $4.66M in Q2 2026.
  • 218 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.